The Race to Save Lives: Comparing Vaccine Development Timelines
Connect with us

Healthcare

The Race to Save Lives: Comparing Vaccine Development Timelines

Published

on

View the full-resolution version of this infographic

vaccine development timeline infographic

Can I share this graphic?
Yes. Visualizations are free to share and post in their original form across the web—even for publishers. Please link back to this page and attribute Visual Capitalist.
When do I need a license?
Licenses are required for some commercial uses, translations, or layout modifications. You can even whitelabel our visualizations. Explore your options.
Interested in this piece?
Click here to license this visualization.

The Race to Save Lives: Vaccine Development Timelines

View the high-resolution of the infographic by clicking here.

Major advancements in medicine have led to a significant increase in average life expectancy, with vaccines being hailed as one of the most successful interventions to date.

In fact, the World Health Organization estimates that vaccines have prevented 10 million deaths between 2010 and 2015 alone. But while some were created and distributed in just over four months, others have taken over 40 years to develop. Then again, previous pandemics have petered out without any vaccine at all.

With approved COVID-19 vaccines soon to be distributed across the globe, the vaccine development process is being scrutinized by experts (and non-experts) the world over.

In the graphic above, we explore how long it has historically taken to bring a vaccine to market during pandemics dating back to the 1900s, and what the process entails.

Pandemic Vaccines of the Past

Although the assumption can be made that developing a vaccine for infectious diseases has become more efficient since the 1900s, that statement is not entirely correct.

It took approximately 25 years to develop a vaccine for the Spanish Flu which killed between 40-50 million people. Similarly, it was only last year that the FDA approved the first Ebola vaccine—an effort that took 43 years since the discovery of the virus.

But while scientists and medical experts have made headway in stopping major pandemics in their tracks, some of the worst outbreaks in history have yet to be cured.

Here is a closer look at the timeframes for vaccine development for every pandemic since the turn of the 20th century:

Name of Pandemic
Death TollTimeframe for Vaccine DevelopmentDuration
Spanish flu40-50 million1917-194225 years
H2N2 Asian flu1.1 millionFeb 1957-Jun 1957<5 months
H3N2 Hong Kong Flu1 millionJul 1968-Nov 1968<5 months
SARS774 (ongoing)2003-present17 years (ongoing)
Ebola11,3001976-201943 years
AIDS25-35 million (ongoing)1981-present39 years (ongoing)
H1N1 Swine Flu151,700 - 575,400Apr 2009-Sept 20096 months
MERS858 (ongoing)2012-present8 years (ongoing)
Coronavirus1.64 million (ongoing)Dec 2019-Nov 202011 months

When it comes to the speedy development of a COVID-19 vaccine, funding has played a vital role. With case numbers growing at an alarming rate, demand and urgency for a vaccine are high. In the U.S., the government paid Pfizer and BioNTech almost $2 billion for 100 million doses of a safe vaccine for COVID-19. This level of support from governments the world over means that pharmaceutical giants have less financial uncertainties to deal with compared to other vaccines.

Even though the global endeavor to distribute COVID-19 vaccines is now underway, many experts are concerned that the pace of approval could compromise long-term safety—but there are rigorous steps a vaccine must first go through before it is approved.

The Journey of a Vaccine Candidate

On average, it takes 10 years to develop a vaccine. According to the CDC, there are six stages involved in the process from start to finish:

  1. Exploratory stage: This stage typically consists of basic lab research that can last anywhere from 2 to 4 years.
  2. Pre-clinical stage: This stage uses tissue-culture or cell-culture systems and animal testing to give researchers an idea of how humans might respond to a candidate vaccine.
  3. Clinical development: Within the clinical development stage, there are three phases. Phase 1 examines the response of a small group of people to a candidate vaccine. Phase 2 involves giving the candidate vaccine to a larger group of people to study its safety, immunogenicity, proposed doses, schedule of immunizations, and method of delivery. In Phase 3, the vaccine is given to thousands of people to further test for efficacy and safety.
  4. Regulatory review and approval: National Regulatory Authorities are responsible for the approval of vaccines in different countries. For example, the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) regulates all U.S. vaccines.
  5. Manufacturing: Typically, it can take anywhere from 6 to 36 months to produce, package, and deliver a high quality vaccine.
  6. Quality control: Different batches of a vaccine are continuously tested by different authorities around the world to ensure its ongoing safety.

Despite these lengthy timeframes, the COVID-19 vaccines and subsequent candidates have overturned the conventional process due to their unconventional technology.

Innovative Technologies Driving COVID’s Cure

Even though there are no approved vaccines for other coronaviruses such as MERS and SARS, previous research into these diseases has helped identify potential solutions for COVID-19 using messenger RNA (mRNA) technology.

“The mRNA vaccine platform technology [which the Pfizer/BioNTech vaccine uses] has been in development for over two decades.”

—Dr Zoltán Kis, Imperial College London.

The technology instructs our bodies to produce a small part of the COVID-19 virus called a spike protein. This triggers the immune system to make antibodies to fight against it and prepares the body for an actual COVID-19 infection.

Containing COVID-19 Batch-by-Batch

Deployment of a safe and effective vaccine could have the potential to save millions of lives and prevent infection for many more.

Although some experts have criticized the speed of vaccine candidate approvals, the quality will be closely monitored on a batch-by-batch basis.

With the COVID-19 crisis showing no signs of slowing down, most of us continue to live in hope that the light is at the end of the tunnel.

Click for Comments

Healthcare

Visualizing the World’s Biggest Pharmaceutical Companies

The world’s biggest pharmaceutical companies are worth $4.1 trillion. Here we map the top 100 companies based on their market cap value.

Published

on

Bubble map of the largest pharmaceutical companies in the world

Who are the World’s Biggest Pharmaceutical Companies?

Some of the world’s biggest pharmaceutical companies have played a central role in the COVID-19 pandemic.

However, it’s likely no surprise that the pandemic has also been great for many healthcare businesses. In fact, in 2020 alone, the world’s 50 largest pharmaceutical companies still combined for a whopping $851 billion in revenues.

In this graphic, using data from Companies Market Cap, we list the largest pharmaceutical companies in the world by market capitalization. It’s worth noting this list also includes healthcare companies that work closely with pharmaceuticals, including biotech, pharmaceutical retailers, clinical laboratories, etc.

Editor’s Note: A previous version of this graphic was missing some key companies such as GSK and AbbVie. They were unfortunately not included in the original source and we are now working to make sure there were no other smaller omissions. Thanks to all that sent in corrections.

The Pharmaceutical Leaders

To start, here are the top five biggest pharmaceutical companies in the world at the moment by market capitalization:

1. Johnson & Johnson

The pharmaceutical and consumer goods giant is worth $428.7 billion in market cap. They developed the third vaccine authorized for use in the U.S. and were named among the TIME100 Most Influential Companies List in 2021.

2. Roche

The Swiss pharmaceutical giant is at the forefront of oncology, immunology, infectious diseases, ophthalmology, and neuroscience. In 2019, Roche’s pharma segment sales rose by a healthy 16% to $53 billion.

3. Pfizer

Despite being the leading COVID-19 vaccine manufacturer in North America, Pfizer slid in the rankings to third place. The company has recently gained momentum, especially in the past quarter, with Q2’2021 revenues of $19.0 billion, reflecting a 86% operational growth from 2020.

4. Eli Lilly

Eli Lilly has taken a significant step towards establishing itself as a pharmaceutical industry leader. Having a market cap value of $125 billion in 2019, Eli Lilly has jumped to a current value of $214.9 billion, a significant growth of 72%.

5. Novartis

The second-biggest pharmaceutical company out of Switzerland, Novartis has been the face of the pharma industry for about 25 years. The primary manufacturer for the most recognizable drugs on the market pulled in a revenue of over $48 billion in 2020, a 3% increase compared to 2019.

Here’s how all the biggest pharmaceutical companies in the world stack up against each other:

Company Rank Company NameMarket Cap ValueCountry
1Johnson & Johnson
JNJ
$428.66 B🇺🇸 USA
2Roche
RHHBY
$320.41 B🇨🇭 Switzerland
3Pfizer
PFE
$219.39 B🇺🇸 USA
4Eli Lilly
LLY
$208.99 B🇺🇸 USA
5Novartis
NVS
$207.70 B🇨🇭 Switzerland
6AbbVie
ABBV
$202.60 B🇺🇸 USA
7Merck
MRK
$191.67 B🇺🇸 USA
8Novo Nordisk
NVO
$187.83 B🇩🇰 Denmark
9Astrazeneca
AZN
$152.28 B🇬🇧 UK
10Bristol-Myers Squibb
BMY
$145.80 B🇺🇸 USA
11Amgen
AMGN
$136.50 B🇺🇸 USA
12Sanofi
SNY
$130.37 B🇫🇷 France
13CVS Health
CVS
$110.49 B🇺🇸 USA
14GlaxoSmithKline
GSK
$104.30 B🇬🇧 UK
15CSL
CSL.AX
$103.10 B🇦🇺 Australia
16Gilead Sciences
GILD
$83.62 B🇺🇸 USA
17Moderna
MRNA
$83.25 B🇺🇸 USA
18Merck KGaA
MRK.DE
$80.61 B🇩🇪 Germany
19Bayer
BAYZF
$59.43 B🇩🇪 Germany
20Jiangsu Hengrui Medicine
600276.SS
$58.51 B🇨🇳 China
21Regeneron Pharmaceuticals
REGN
$55.83 B🇺🇸 USA
22Biogen
BIIB
$55.00 B🇺🇸 USA
23BioNTech
BNTX
$54.23 B🇩🇪 Germany
24Takeda Pharmaceutical
TAK
$52.67 B🇯🇵 Japan
25Lonza
LONN.SW
$52.16 B🇨🇭 Switzerland
26Walgreens Boots Alliance
WBA
$45.05 B🇺🇸 USA
27Celltrion
068270.KS
$33.80 B🇰🇷 S. Korea
28Astellas Pharma
ALPMF
$33.42 B🇯🇵 Japan
29BeiGene
BGNE
$31.65 B🇨🇳 China
30Eisai
4523.T
$31.20 B🇯🇵 Japan
31West Pharma
WST
$26.59 B🇺🇸 USA
32Hansoh Pharma
3692.HK
$26.00 B🇨🇳 China
33LabCorp
LH
$25.97 B🇺🇸 USA
34Otsuka Holdings
4578.T
$23.15 B🇯🇵 Japan
35Horizon Therapeutics
HZNP
$21.13 B🇮🇪 Ireland
36Alnylam Pharmaceuticals
ALNY
$20.42 B🇺🇸 USA
37kyowa Kirin
4151.T
$18.85 B🇯🇵 Japan
38Catalent
CTLT
$18.74 B🇺🇸 USA
39Sino Biopharmaceutical
1177.HK
$18.48 B🇭🇰 Hong Kong
40Bio-Techne
TECH
$17.25 B🇺🇸 USA
41PPD
PPD
$16.26 B🇺🇸 USA
42Argenx
ARGX
$16.03 B🇳🇱 Netherlands
43Shionogi
4507.T
$15.29 B🇯🇵 Japan
44Dr. Reddy's
RDY
$11.88 B🇮🇳 India
45Teva Pharmaceutical Industries
TEVA
$11.21 B🇮🇱 Israel
46Ono Pharmaceutical
4528.T
$11.12 B🇯🇵 Japan
47ICON plc
ICLR
$11.09 B🇮🇪 Ireland
48Bausch Health
BHC
$10.47 B🇨🇦 Canada
49CRISPR Therapeutics
CRSP
$10.42 B🇨🇭 Switzerland
50Curevac
CVAC
$10.33 B🇩🇪 Germany
51Hualan Biological Engineering
002007.SZ
$10.31 B🇨🇳 China
52Vifor Pharma
VIFN.SW
$9.49 B🇨🇭 Switzerland
53Neurocrine Biosciences
NBIX
$9.45 B🇺🇸 USA
54Sinopharm
1099.HK
$9.42 B🇨🇳 China
55BridgeBio Pharma
BBIO
$8.89 B🇺🇸 USA
56Cadila Healthcare
CADILAHC.NS
$8.59 B🇮🇳 India
57Sumitomo Dainippon Pharma
4506.T
$8.16 B🇯🇵 Japan
58Tilray
TLRY
$7.89 B🇨🇦 Canada
59Ascendis Pharma
ASND
$7.51 B🇩🇰 Denmark
60Evotec
EVT.F
$7.19 B🇩🇪 Germany
61Lupin Limited
LUPIN.NS
$7.04 B🇮🇳 India
62Gland Pharma
GLAND.NS
$7.01 B🇮🇳 India
63Exelixis
EXEL
$6.95 B🇺🇸 USA
64GW Pharmaceuticals
GWPH
$6.81 B🇬🇧 UK
65KOBAYASHI Pharmaceutical
4967.T
$6.78 B🇯🇵 Japan
66Torrent Pharmaceuticals
TORNTPHARM.NS
$6.61 B🇮🇳 India
67Biocon
BIOCON.NS
$6.43 B🇮🇳 India
68PeptiDream
4587.T
$6.32 B🇯🇵 Japan
69Sarepta Therapeutics
SRPT
$6.25 B🇺🇸 USA
70Perrigo
PRGO
$6.21 B🇮🇪 Ireland
71Orion Corporation
ORNAV.HE
$6.11 B🇫🇮 Finland
72Lundbeck
LDB.F
$6.04 B🇩🇰 Denmark
73AbCellera
ABCL
$5.87 B🇨🇦 Canada
74Adaptive Biotechnologies
ADPT
$5.69 B🇺🇸 USA
75Intellia Therapeutics
NTLA
$5.62 B🇺🇸 USA
76Santen Pharmaceutical
4536.T
$5.49 B🇯🇵 Japan
77Nippon Shinyaku
4516.T
$5.46 B🇯🇵 Japan
78Beam Therapeutics
BEAM
$5.43 B🇺🇸 USA
79Reata Pharmaceuticals
RETA
$5.15 B🇺🇸 USA
80Swedish Orphan Biovitrum
SOBI.ST
$5.13 B🇸🇪 Sweden
81BB Biotech
BION.SW
$5.08 B🇨🇭 Switzerland
82Alkem Laboratories
ALKEM.NS
$5.00 B🇮🇳 India
83Abbott India
ABBOTINDIA.NS
$4.69 B🇮🇳 India
84Laurus Labs
LAURUSLABS.NS
$4.44 B🇮🇳 India
85Taisho Pharmaceutical
4581.T
$4.39 B🇯🇵 Japan
86Hanmi Pharmaceutical
008930.KS
$4.22 B🇰🇷 S. Korea
87Alkermes
ALKS
$3.87 B🇮🇪 Ireland
88Karuna Therapeutics
KRTX
$3.71 B🇺🇸 USA
89Shinpoong Pharm
019170.KS
$3.65 B🇰🇷 S. Korea
90NantKwest
NK
$3.55 B🇺🇸 USA
91Ipca Laboratories
IPCALAB.NS
$3.41 B🇮🇳 India
92Nektar Therapeutics
NKTR
$3.02 B🇺🇸 USA
93BioCryst Pharmaceuticals
BCRX
$3.01 B🇺🇸 USA
94Vericel
VCEL
$2.96 B🇺🇸 USA
95Dicerna Pharmaceuticals
DRNA
$2.84 B🇺🇸 USA
96Rocket Pharmaceuticals
RCKT
$2.74 B🇺🇸 USA
97Axsome Therapeutics
AXSM
$2.65 B🇺🇸 USA
98Natco Pharma
NATCOPHARM.NS
$2.63 B🇮🇳 India
99Alembic Pharmaceuticals
APLLTD.NS
$2.59 B🇮🇳 India
100Editas Medicine
EDIT
$2.54 B🇺🇸 USA

World’s Largest Pharmaceutical Exporters and Importers

According to the World Trade Organization (WTO), these countries exported the most number of pharmaceuticals in the year 2019:

RankCountryExport Value (US$B)
1🇩🇪 Germany$91.4
2🇨🇭 Switzerland$84.8
3🇺🇸 U.S.$55.7
4🇧🇪 Belgium$55.7
5🇮🇪 Ireland$55.4

In contrast, here are the biggest importers over the same period.

RankCountryImport Value (US$B)
1🇺🇸 U.S.$132.4
2🇩🇪 Germany$59.4
3🇧🇪 Belgium$47.3
4🇨🇳 China$35.7
5🇳🇱 Netherlands$33.5

This position is hardly surprising for the U.S., where six of the world’s top 10 pharmaceutical companies are headquartered. The country also captures 45% of the global market.

The Future of Pharmaceutical Companies

If the response to the COVID-19 pandemic has taught us anything, it is that in building a patient-centered future, the pharmaceutical industry plays a key role. It has to constantly find new ways to customize medicines while researching and developing new tools and drugs.

By embracing disruptive technologies like 3D printed drugs, artificial intelligence guided therapies, and preventive medicine while working with regulatory agencies, the pharmaceutical companies will benefit from having a digital revolution.

Furthermore, emerging markets will have a more significant say in the global pharmaceutical market in the coming years. Even though ‘big pharma’ will keep raking in the massive profits they do every year, their reliance on countries like Brazil and India for research and drug production will significantly impact the years to come.

Continue Reading

Economy

When Will Your Country Recover from the Pandemic?

The path to COVID-19 recovery varies worldwide—some countries have already recovered, while others will not be back to normal for years.

Published

on

covid-19 recovery

What started as a novel virus in China quickly became a sweeping disease that shut down the world and put a 1.5 year halt on the global economy.

But while some countries’ economies are already back to normal, others are lagging far behind.

COVID-19 Recovery Timelines, by OECD Country

This chart using data from the OECD anticipates when countries will economically recover from the global pandemic, based on getting back to pre-pandemic levels of GDP per capita.

Note: The categorization of ‘advanced’ or ‘emerging’ economy was determined by OECD standards.

covid-19 recovery time by country

Can I share this graphic?
Yes. Visualizations are free to share and post in their original form across the web—even for publishers. Please link back to this page and attribute Visual Capitalist.
When do I need a license?
Licenses are required for some commercial uses, translations, or layout modifications. You can even whitelabel our visualizations. Explore your options.
Interested in this piece?
Click here to license this visualization.

The Leaders of the Pack

At the top, China and the U.S. are recovering at breakneck speed. In fact, recovering is the wrong word for China, as they reached pre-pandemic GDP per capita levels just after Q2’2020.

On the other end, some countries are looking at years—not months—when it comes to their recovery date. Saudi Arabia isn’t expected to recover until after Q1’2024, and Argentina is estimated to have an even slower recovery, occurring only after Q2’2026.

CountryRecoveryEconomy
🇧🇪 BelgiumAfter Q4 2022Advanced
🇸🇪 SwedenAfter Q4 2021Advanced
🇸🇰 SlovakiaAfter Q4 2021Advanced
🇳🇿 New ZealandAfter Q4 2021Advanced
🇩🇪 GermanyAfter Q4 2021Advanced
🇪🇪 EstoniaAfter Q4 2021Advanced
🇩🇰 DenmarkAfter Q4 2021Advanced
🇮🇸 IcelandAfter Q3 2023Advanced
🇸🇮 SloveniaAfter Q3 2022Advanced
🇵🇹 PortugalAfter Q3 2022Advanced
🇫🇷 FranceAfter Q3 2022Advanced
🇦🇹 AustriaAfter Q3 2022Advanced
🇵🇱 PolandAfter Q3 2021Advanced
🇳🇴 NorwayAfter Q3 2021Advanced
🇱🇺 LuxembourgAfter Q3 2021Advanced
🇱🇻 LatviaAfter Q3 2021Advanced
🇯🇵 JapanAfter Q3 2021Advanced
🇫🇮 FinlandAfter Q3 2021Advanced
🇪🇸 SpainAfter Q2 2023Advanced
🇬🇧 United KingdomAfter Q2 2022Advanced
🇳🇱 NetherlandsAfter Q2 2022Advanced
🇮🇹 ItalyAfter Q2 2022Advanced
🇬🇷 GreeceAfter Q2 2022Advanced
🇨🇿 Czech RepublicAfter Q2 2022Advanced
🇨🇦 CanadaAfter Q2 2022Advanced
🇺🇸 United StatesAfter Q2 2021Advanced
🇰🇷 South KoreaAfter Q2 2021Advanced
🇮🇪 IrelandAfter Q2 2021Advanced
🇨🇭 SwitzerlandAfter Q1 2022Advanced
🇮🇱 IsraelAfter Q1 2022Advanced
🇭🇺 HungaryAfter Q1 2022Advanced
🇦🇺 AustraliaAfter Q1 2022Advanced
🇱🇹 LithuaniaAfter Q1 2021Advanced
🇿🇦 South AfricaAfter Q4 2022Emerging
🇮🇩 IndonesiaAfter Q4 2021Emerging
🇮🇳 IndiaAfter Q4 2021Emerging
🇲🇽 MexicoAfter Q3 2023Emerging
🇨🇴 ColombiaAfter Q3 2022Emerging
🇧🇷 BrazilAfter Q3 2022Emerging
🇨🇱 ChileAfter Q3 2021Emerging
🇹🇷 TurkeyAfter Q3 2020Emerging
🇦🇷 ArgentinaAfter Q2 2026Emerging
🇨🇷 Costa RicaAfter Q2 2023Emerging
🇷🇺 RussiaAfter Q2 2021Emerging
🇨🇳 ChinaAfter Q2 2020Emerging
🇸🇦 Saudi ArabiaAfter Q1 2024Emerging

Most countries will hit pre-pandemic levels of GDP per capita by the end of 2022. The slowest recovering advanced economies—Iceland and Spain—aren’t expected to bounce back until 2023.

Four emerging economies are speeding ahead, and are predicted to get back on their feet by the end of this year or slightly later (if they haven’t already):

  • 🇷🇺 Russia: after Q2’2021
  • 🇨🇱 Chile: after Q3’2021
  • 🇮🇳 India: after Q4’2021
  • 🇮🇩 Indonesia: after Q4’2021

However, no recovery is guaranteed, and many countries will continue face setbacks as waves of COVID-19 variants hit—India, for example, was battling its biggest wave as recently as May 2021.

Trailing Behind

Why are some countries recovering faster than others? One factor seems to be vaccination rates.

CountryDoses Administered per 100 PeopleTotal Doses AdministeredPercent of Population Fully Vaccinated
World473,573,004,544
🇦🇪 U.A.E.16616,194,52669%
🇲🇹 Malta143718,41871%
🇧🇭 Bahrain1362,224,91663%
🇮🇸 Iceland129466,43470%
🇺🇾 Uruguay1294,458,39458%
🇨🇱 Chile12824,248,54560%
🇦🇼 Aruba125133,42159%
🇶🇦 Qatar1233,474,94456%
🇬🇧 United Kingdom12281,438,89253%
Mongolia1213,912,99656%
Israel12110,959,63358%
Canada11844,293,65948%
Singapore1136,440,73542%
Belgium11112,700,51346%
Curaçao108170,85751%
Denmark1086,266,89243%
Maldives106561,74846%
Netherlands10518,273,23843%
Spain10549,585,19749%
Hungary10410,155,46654%
Portugal10310,579,25944%
Luxembourg102633,97441%
Germany10284,989,85045%
China1021,426,347,000
United States101336,054,95348%
Ireland1014,995,71944%
Austria1008,866,47444%
Italy9959,966,90841%
Switzerland958,133,48642%
France9362,321,35540%
Sweden939,536,16436%
Finland904,951,92526%
Norway894,785,93731%
Greece899,560,59242%
Lithuania882,459,60542%
Czech Republic889,346,39738%
Poland8532,413,19942%
Dominican Rep.849,066,15134%
Estonia791,049,41634%
Serbia785,415,43438%
Slovenia781,626,07236%
Cyprus76916,81935%
Turkey7461,747,39923%
Slovakia734,003,63933%
Mauritius71901,53024%
Croatia712,870,86632%
Macau69434,72627%
Cuba697,767,60117%
Latvia661,264,43333%
Bhutan64487,0600.02%
Saudi Arabia6321,556,3149.2%
Hong Kong624,638,90826%
Barbados59168,95525%
Argentina5826,134,81511%
Brazil57120,726,75216%
Kuwait562,375,45522%
Morocco5620,584,81226%
Cambodia56924292524%
El Salvador533,422,21420%
Japan5366,714,52820%
Costa Rica522,606,79116%
French Polynesia51141,52324%
Montenegro49304,65523%
Fiji47419,9988%
Romania479,092,14124%
Guyana46363,44216%
Colombia4522,624,56819%
Jordan454,498,74818%
Azerbaijan424,242,72717%
Panama421,781,54215%
Mexico4152,704,96017%
Malaysia4113,107,68113%
South Korea4121,157,61212%
New Caledonia40115,21819%
Ecuador406,890,87610%
Kazakhstan397,303,18014%
Suriname38222,3778%
Australia389,631,80710%
Belize38147,08010%
Albania371,052,10816%
Russia3550,383,63814%
Oman351,728,6186%
North Macedonia34713,11413%
Samoa3262,1614.7%
Moldova31834,52713%
Grenada3135,07213%
Peru319,954,42912%
Saint Lucia3054,36113%
Sri Lanka296,431,1007.3%
India29391,340,4916%
New Zealand291,404,34311%
Brunei28121,2414.3%
Tonga2728,667
Bulgaria271,896,57412%
Bolivia273,117,5217%
Trinidad and Tobago27375,92411%
Bahamas2597,99210%
Lebanon251,693,1649%
Laos241,708,9819%
Saint Vincent and the Grenadines2325,509
Cape Verde23124,9583%
Timor-Leste22281,2833%
Indonesia2155,819,7816%
Equatorial Guinea21279,1129%
West Bank & Gaza20958,5199%
Thailand1913,533,7175%
Taiwan194,603,6391%
Tunisia192,206,9806%
São Tomé and Príncipe1837,7165%
Bosnia and Herzegovina14470,2185%
Venezuela144,000,0004%
Nepal133,730,3444%
Philippines1314,074,5144%
Botswana12284,6765%
Honduras121,172,8301%
Paraguay12826,6422%
Belarus
Zimbabwe111,575,5394%
Comoros1190,880
Uzbekistan113,541,4424%
Pakistan102,166,06502%
Jamaica9.8290,3824%
Armenia8.8260,8132%
Ukraine8.83,899,8903%
Iran7.96,530,1243%
Georgia7.8289,3993%
South Africa7.74,535,2223%
Guatemala6.91,146,4771%
Namibia6.7166,6161%
Myanmar6.5*3,500,000
Libya6.3425,119
Bangladesh6.210,108,2243%
Guinea6770,6882%
Algeria
Eswatini5.260,0692%
Rwanda5.1646,9092%
Senegal5.1823,6102%
Angola4.91,558,2012%
Egypt4.84,851,3491%
Vanuatu4.714,026
Vietnam4.34,185,6230.3%
Togo
Tajikistan4.3397,6940.2%
Ghana4.21,265,3061%
Mauritania4182,6420.3%
Solomon Islands3.825,6281%
Ivory Coast3.3861,278
Gabon3.372,3511%
Republic of the Congo3163,742
Kenya2.91,550,3891%
Sierra Leone2.9225,3800.2%
Iraq2.81,087,8661%
Djibouti2.826,796
Afghanistan2.71,024,1681%
Kyrgyzstan2.7173,7001.%
Lesotho2.756,3221%
Nicaragua
Uganda2.41,079,943
Malawi2.3428,4070.2%
Nigeria23,938,9451%
Liberia1.995,4230.2%
Ethiopia1.92,090,997
Gambia1.943,5571%
Niger1.8423,3350.3%
Mozambique1.7508,1841%
Central African Republic1.778,685
Somalia1.6249,7901%
Sudan1.6677,9570.3%
Zambia1.4243,8180.3%
Guinea-Bissau1.325,0120.1%
Yemen1297,405<0.1%
Mali1196,8620.3%
Syria0.8131,2210.1%
Madagascar0.7197,001
Turkmenistan
Cameroon0.6163,9210.1%
Papua New Guinea0.651,170<0.1%
South Sudan0.555,915<0.1%
Benin0.452,5630.1%
Burkina Faso0.233,960<0.1%
Chad0.224,459<0.1%
Congo0.173,764<0.1%

As of July 16th, 2021.

The higher the rate of vaccination, the harder it is for COVID-19 to spread. This gives countries a chance to loosen restrictions, let people get back to work and regular life, and fuel the economy. Additionally, the quicker vaccines are rolled out, the less time there is for variants to mutate.

Another factor is the overall strength of a country’s healthcare infrastructure. More advanced economies often have more ICU capacity, more efficient dissemination of public health information, and, simply, more hospital staff. These traits help better handle the pandemic, with reduced cases, less restrictions, and a speedy recovery.

Finally, the level of government support and fiscal stimulus injected into different economies has determined how swiftly they’ve recovered. Similar to the disparity in vaccine rollouts, there was a significant fiscal stimulus gap, especially during the heat of the pandemic.

Recovering to Normal?

Many experts and government leaders are now advocating for funneling more money into healthcare infrastructure and disease research preventatively. The increased funding now would help stop worldwide shut downs and needless loss of life in future.

Time will tell when we return to “normal” everywhere, however, normal will likely never be the same. Many impacts of the global pandemic will stay with us over the long term.

Continue Reading

Subscribe

Popular